Obesity and coronary heart disease

American Journal of the Medical Sciences

Volumn 321, Issue 4, 2001, Pages 215-224

  Alexander, James K ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Central obesity; Coronary heart disease; Epidemiologic studies; Non traditional coronary risk factors; Obesity; Traditional coronary risk factors

Indexed keywords

LIPOPROTEIN A;

ANGIOCARDIOGRAPHY; AUTOPSY; BODY FAT; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM CELL; EPIDEMIOLOGICAL DATA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; THROMBOGENESIS; WEIGHT REDUCTION;

EID: 0035060476     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200104000-00002     Document Type: Conference Paper

References (139)

1. Increasing prevalence of overweight among U.S. adults. The National Health and Nutrition Examination Surveys 1960-1991
2. New developments in childhood obesity
3. Increasing pediatric obesity in the United States
4. Total and visceral adipose tissue volumes derived from measurements with computed tomography in adult men and women: Predictive equations
5. Indices of relative body weight and ideal weight charts
6. Does body mass index adequately capture the relation of body composition and body size to health outcomes?
7. Basic and clinical aspects of regional fat distribution
8. Mortality of severely obese subjects
9. A meta-analysis of physical activity in the prevention of coronary heart disease
10. Obesity and coronary heart disease
11. Obesity, atherosclerosis, and coronary heart disease
12. Body mass index and body girths as predictors of mortality in black and white women
13. Abdominal fat distribution and disease: An overview of epidemiological data
14. Upper body fat distribution: A hyperinsulinemia-independent predictor of coronary heart disease mortality - The Paris Prospective Study
15. Abdominal adiposity and coronary heart disease in women
16. Relationship of various factors to the degree of coronary atherosclerosis in women
17. Atherosclerosis in an autopsy series
18. Coronary artery disease in men eighteen to thirty nine years of age
19. Relationship of body weight to acute myocardial infarction
20. Obesity, body weight, body length and atherosclerosis
21. Atherosclerosis and body build
22. Risk factors and atherosclerotic lesions: A review of autopsy studies
23. The cardiac pathology of obesity
24. Obesity and congestive heart failure
25. The heart in massive (more than 300 pounds or 136 kilograms) obesity. Analysis of 12 patients studied at necropsy
26. Association between cardiac pathology and fat tissue distribution in an autopsy series of men without premortem evidence of cardiovascular disease
27. Coronary heart disease in young black and white males in New Orleans: Community Pathology Study
28. Relation of glycohemoglobin and adiposity to atherosclerosis in youth
29. Indices of obesity and body fat distribution in angiographically defined coronary artery disease in men
30. Coronary arteriosclerosis in relation to body fatness and its distribution
31. Obesity, distribution of body fat and coronary disease in black women
32. Angiographically determined coronary artery disease in relation to obesity and body fat distribution
33. Progression of coronary atherosclerosis
34. Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program
35. The association of waist hip ratio and angiographically determined coronary artery disease
36. Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease
37. Task Force I. Pathogenesis of coronary disease: The biologic role of risk factors
38. Impairment of health and quality of life using new US federal guidelines for the identification of obesity
39. Obesity, lipids, cardiovascular risk and androgen excess
40. Obesity and its relation to cardiovascular disease risk factors in Canadian adults
41. Excess body weight: An under-recognized contributor to dyslipidemia in white American women
42. Is non-central obesity metabolically benign? Implications for prevention from a population survey
43. Adipose tissue distribution and plasma lipoprotein levels in obese women: Importance of intra-abdominal fat
44. Insulin resistance in visceral obesity
45. Weight and blood pressure. Findings in hypertension screening of 1 million Americans
46. Body height and body mass as determinants of basal blood pressure in children. The Bogalusa Heart Study
47. Influence of race, sex, and weight on blood pressure behavior in young adults
48. Blood pressure and body index patterns: A longitudinal study
49. Hypertension in childhood obesity
50. The relation of adiposity to blood pressure and development of hypertension: The Framingham Study
51. Observations on some clinical features of extreme obesity with particular reference to cardiorespiratory effects
52. Health implications of obesity. National Institutes of Health Consensus Development Conference StatementAnonymous
53. Health implications of obesity
54. Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus
55. Increase in fasting insulin and glucose over seven years with increasing weight of young adults: The CARDIA Study
56. Weight change and diabetes incidence: Findings from a national cohort of US adults
57. Homocysteine and risk of cardiovascular disease among postmenopausal women
58. A prospective study of homocysteine and risk of myocardial infarction in US physicians
59. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
60. Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile
61. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
62. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
63. Homocysteine and arteriosclerosis
64. New risk factors for coronary heart disease in Asia
65. Vitamin supplementation during weight reduction-favorable effect on homocysteine metabolism
66. Occurrence of hyperhomocysteinemia 1 year after gastroplasty for severe obesity
67. Vitamin B-12 deficiency after gastric surgery for obesity
68. Lipoprotein (a) in android obesity and NIDDM
69. Anthropometry and lipoprotein-related characteristics of young adult males in Taiwan
70. Effects of visceral fat and weight loss on lipoprotein (a) concentration in subjects with obesity
71. Relation between sex hormones and serum lipoprotein and lipoprotein(a) concentrations in premenopausal obese women
72. Abdominal obesity as an important component of insulin resistance syndrome
73. Abdominal obesity
74. Association between circulating TNF concentrations and visceral fat distribution
75. Temporal relations between obesity and insulin: Longitudinal data from the Normative Aging Study
76. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
77. Hyperinsulinism in patients with coronary disease
78. Hyperinsulinemia as an independent risk factor for ischemic heart disease
79. Hyperinsulinemia and the risk of coronary heart disease
80. Serum insulin and incident coronary heart disease in middle aged British men
81. Insulin and risk of cardiovascular disease. A meta-analysis
82. The pathogenesis of atherosclerosis: A perspective for the 1990s
83. Insulin and vasculature. Old actors, new roles
84. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
85. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium dependent blood flow in obesity
86. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of the troglitazone
87. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation
88. Von Willebrand factor and the endothelium
89. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
90. Von Willebrand factor, the endothelium and obesity
91. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
92. Hemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study
93. ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
94. Blood coagulation and fibrinolysis in obese NIDDM patients
95. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
96. Abdominal obesity is associated with an impaired fibrimolytic activity and elevated plasminogen activator inhibitor-1
97. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
98. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
99. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women
100. Production of plasminogen activator inhibitor 1 by human adipose tissuepossible link between visceral fat accumulation and vascular disease
101. Rethinking obesity, an alternative view of its health implications
102. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
103. Longevity of man: Relating weight and fatness in middle age
104. Obesity and heart disease: A statement for healthcare professionals from the nutrition committees, American Heart Association
105. Relation of body weight to development of ischemic heart disease in a cohort of young North Americans after a 26 year observation period: The Manitoba Study
106. Weight and thirty-year mortality of men in the Framingham Study
107. Body weight and mortality among women
108. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
109. Regional distribution of body fat, plasma lipoproteins and cardiovascular disease
110. Genetic and non-genetic determinants of regional fat distribution
111. Nutritional management of plasma lipid disorders
112. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women
113. Long-term effects of weight reduction on serum lipids and plasma insulin in obese children
114. Body-fat distribution and changes in atherogenic risk-factor profile in obese adolescent girls during weight reduction
115. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral obesity
116. Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women
117. Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity
118. Serum lipids after gastric bypass for morbid obesity
119. Obesity-related hypertension: Its physiological basis and pharmacological approaches to its treatment
120. Obesity and hypertension: Epidemiological and clinical issues
121. The effects of weight reduction on blood pressure in 301 obese subjects
122. Obesity and hypertension. Demonstration of a "floor" effect
123. The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients
124. Effects of fasting and refeeding on blood pressure are determined by nutritional state, not by body weight change
125. Obesity-related hypertension: Evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status
126. Cardiovascular changes after weight loss in obesity hypertension
127. Cardiac effects of weight reduction in obesity hypertension
128. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight, hypertensive patients
129. Improvements of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity
130. Improvement of multiple coronary risk factors in obese hypertensives by reduction of intra-abdominal visceral fat
131. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals
132. The effect of weight loss and apoprotein E polymorphism on serum lipids, apoproteins A-I and B, and lipoprotein (a)
133. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults
134. Effect of weight loss on coagulation factors VII and X
135. Reduction of elevated plasminogen activator inhibitor levels during modest weight loss
136. Plasminogen activator inhibitor1 tissue type plasminogen activator, and fibrinogen. Effect of dieting with or without exercise in overweight postmenopausal women
137. Weight change in middleaged British men: Implications for health
138. Prospective study of intentional weight loss and mortality in never-smoking US white women aged 40-64 years
139. The association between weight loss and longevity. A review of the evidence